MCID: PLM068
MIFTS: 38

Pulmonary Vein Stenosis malady

Categories: Rare diseases, Cardiovascular diseases

Aliases & Classifications for Pulmonary Vein Stenosis

About this section

Aliases & Descriptions for Pulmonary Vein Stenosis:

Name: Pulmonary Vein Stenosis 45 65
 
Pulmonary Veins Stenosis 45

Classifications:



External Ids:

UMLS65 C0340756

Summaries for Pulmonary Vein Stenosis

About this section
NIH Rare Diseases:45 Pulmonary vein stenosis is a very rare and serious condition in which there is a blockage in the blood vessels that bring oxygen-rich blood from the lungs back to the heart. this condition can be isolated to one vein, but often affects multiple veins. stenosis occurs when there is an abnormal thickening and narrowing of the walls of the veins. pulmonary vein stenosis is a progressive condition and may lead to total obstruction to a blood vessel. most commonly, all of the pulmonary veins of one lung are affected, causing pulmonary hypertension and pulmonary arterial hypertension. surgery and catheterization to widen the narrow veins is usually a short-term solution since the obstruction typically recurs. last updated: 9/1/2011

MalaCards based summary: Pulmonary Vein Stenosis, also known as pulmonary veins stenosis, is related to atrial fibrillation and esophageal lipoma. An important gene associated with Pulmonary Vein Stenosis is DES (Desmin), and among its related pathways are Striated Muscle Contraction and Cardiac Progenitor Differentiation. Affiliated tissues include lung, heart and t cells, and related mouse phenotype cellular.

Wikipedia:68 Pulmonary vein stenosis is a rare cardiovascular disorder. It is recognized as being the stenosis of one... more...

Related Diseases for Pulmonary Vein Stenosis

About this section

Diseases related to Pulmonary Vein Stenosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 79)
idRelated DiseaseScoreTop Affiliating Genes
1atrial fibrillation10.6
2esophageal lipoma10.5ACTC1, DES
3congenital fibrosis of the extraocular muscles10.5ACTC1, DES
4benign multicystic peritoneal mesothelioma10.5ACTC1, DES
5benign mesothelioma10.5ACTC1, DES
6adult mesoblastic nephroma10.5ACTC1, DES
7iris spindle cell melanoma10.5ACTC1, DES
8pulmonary immaturity10.5ACTC1, DES
9benign deep fibrous histiocytoma10.5ACTC1, DES
10thymus lipoma10.5ACTC1, DES
11epidermal appendage tumor10.5ACTC1, DES
12struma ovarii10.5ACTC1, DES
13kidney rhabdoid cancer10.5ACTC1, DES
14proliferative fasciitis10.4ACTC1, DES
15hepatic angiomyolipoma10.4ACTC1, DES
16familial syringomyelia10.4CD99, DES
17severe combined immune deficiency, autosomal recessive t cell-negative, b cell-positive, nk cell-positive, il7r-related10.4ACTC1, DES
18small intestine leiomyosarcoma10.4ACTC1, MKI67
19developmental dysphasia familial10.3CD99, DES
20oral tuberculosis10.3ACTC1, DES
21malignant dermis tumor10.3ACTC1, CD99
22autosomal dominant charcot-marie-tooth disease type 2a210.3ACTC1, DES
23orbit embryonal rhabdomyosarcoma10.3ACTC1, CD99
24transverse vaginal septum10.3ACTC1, DES
25myelomeningocele10.3CD99, DES
26conventional fibrosarcoma10.3CD99, MKI67
27large cell neuroendocrine carcinoma10.2ACTC1, DES
28liver rhabdomyosarcoma10.2CD99, DES
29conjunctival nevus10.1ACTC1, DES
30uterine corpus endometrial stromal sarcoma10.1ACTC1, DES
31epidermolysis bullosa acquisita10.1ACTC1, DES, MKI67
32melanoma10.1ACTC1, DES, MKI67
33renal tubular acidosis, distal, autosomal recessive10.1DES, PDGFRA
34myoclonic cerebellar dyssynergia10.1ACTC1, DES, MKI67
35small cell neuroendocrine carcinoma10.1MKI67, PDGFRA
36pulmonary hypertension10.1
37bone angioendothelial sarcoma10.1CD99, PDGFRA
38fallopian tube transitional cell carcinoma10.1MKI67, PDGFRA
39mediastinitis10.0
40fibrosing mediastinitis10.0
41lung disease10.0
42cor triatriatum10.0
43spermatogenic failure 1310.0CD99, DES, MKI67
44cellular schwannoma10.0DES, PDGFRA
45adenosquamous carcinoma10.0MKI67, PECAM1
46fallopian tube carcinosarcoma10.0ACTC1, DES, PDGFRA
47bronchopulmonary dysplasia9.9
48heart disease9.9
49down syndrome9.9
50congenital heart disease9.9

Graphical network of the top 20 diseases related to Pulmonary Vein Stenosis:



Diseases related to pulmonary vein stenosis

Symptoms for Pulmonary Vein Stenosis

About this section

Drugs & Therapeutics for Pulmonary Vein Stenosis

About this section

Drugs for Pulmonary Vein Stenosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 78)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Adenosineapproved, investigationalPhase 436358-61-760961
Synonyms:
(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose
1-(6-Amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose
1odi
2fqy
2gl0
30143-02-3
4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside
46946-45-6
46969-16-8
58-61-7
6-Amino-9-.beta.-ribofuranosyl-9H-purine
6-Amino-9-beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-D-ribofuranosyl-9H-purine
6-Amino-9beta-delta-ribofuranosyl-9H-purine
9-(beta-D-Arabinofuranosyl)adenine
9-beta-D-Arabinofuranosyladenine
9-beta-D-Ribofuranosidoadenine
9-beta-D-Ribofuranosyl-9H-purin-6-amine
9-beta-D-Ribofuranosyladenine
9-beta-delta-Arabinofuranosyladenine
9-beta-delta-Ribofuranosidoadenine
9-beta-delta-Ribofuranosyl-9H-purin-6-amine
9-beta-delta-Ribofuranosyladenine
9beta-D-Ribofuranosyladenine
9beta-D-ribofuranosyl-9H-Purin-6-amine
9beta-delta-Ribofuranosyladenine
9beta-delta-ribofuranosyl-9H-Purin-6-amine
A0152
A4036_SIGMA
A9251_SIGMA
AC1L1U8O
AC1Q1ID3
AC1Q52XU
ADN
AI3-52413
Ade-Rib
Ade-rib
Adenin riboside
Adenine 9-beta-D-arabinofuranoside
Adenine deoxyribonucleoside
Adenine nucleoside
Adenine riboside
Adenine-9-beta-D-ribofuranoside
Adenine-9beta-D-Ribofuranoside
Adenine-9beta-delta-Ribofuranoside
Adenocard
Adenocard (TN)
Adenocard, Adenosine
Adenocor
Adenoscan
Adenoscan (TN)
Adenosin
Adenosin [German]
Adenosina
Adenosine
Adenosine (JAN/USP)
Adenosine [USAN:BAN]
Adenosine, homopolymer
Adenosinum
Adensoine
Adenyldeoxyriboside
Ado
Adénosine
BB_NC-0565
BSPBio_001796
Bio1_000437
 
Bio1_000926
Bio1_001415
Boniton
C00212
CCRIS 2557
CHEBI:16335
CHEMBL477
CID60961
Caswell No. 010B
D000241
D00045
DB00640
Deoxyadenosine
Desoxyadenosine
EA6C60C2-6AFB-4264-A2F0-541373DB950E
EINECS 200-389-9
FT-0082881
HMS1920A13
HMS2091G13
KBio3_001296
LS-15085
MEDR-640
MLS000069638
MLS002153227
MolPort-001-838-229
Myocol
NCGC00023673-03
NCGC00023673-04
NCGC00023673-05
NCGC00023673-06
NCGC00023673-07
NSC 627048
NSC 7652
NSC627048
NSC7652
Nucleocardyl
Pallacor
Polyadenosine
Polyriboadenosine
S1647_Selleck
SDCCGMLS-0003108.P003
SMR000058216
SPBio_001194
SPECTRUM1500107
SR 96225
SR-96225
SUN-Y4001
Sandesin
Spectrum2_001257
Spectrum3_000288
TL8003749
UNII-K72T3FS567
USAF CB-10
V0098
Vidarabine
ZINC02169830
adenine-D-ribose
adenosine
b-D-Adenosine
beta-Adenosine
beta-D-Adenosine
beta-D-Ribofuranoside, adenine-9
beta-delta-Adenosine
bmse000061
nchembio.143-comp9
nchembio.186-comp109
nchembio.2007.56-comp13
nchembio.64-comp4
nchembio706-5
2
Tadalafilapproved, investigationalPhase 4140171596-29-5110635
Synonyms:
(6R,12AR)-2,3,6,7,12,12a-hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione
171596-29-5
1xoz
6-BENZO[1,3]dioxol-5-yl-2-methyl-2,3,6,7,12,12a-hexahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
AC1L380B
ADCIRCA
Acdirca
Adcirca
C429886
CHEBI:41488
CHEMBL779
CID110635
CPD000466321
Cialis
Cialis (TN)
Cialis, GF 196960, IC 351, ICOS 351, Tadalafil
D02008
DB00820
FT-0080116
GF 196960
GF-196960
 
HMS2051N17
HSDB 7303
IC 351
IC-351
ICOS 351
Ic351
KS-1117
LS-186558
LS-187015
LS-187770
Lilly brand of tadalafil
MLS000759426
MLS001165782
MLS001195644
MLS001424132
MolPort-002-885-864
S1512_Selleck
SAM001246586
SMR000466321
Tadalafil
Tadalafil (JAN/USAN/INN)
Tadalafil [USAN]
Tadanafil
UNII-742SXX0ICT
ZINC03993855
3
PropafenoneapprovedPhase 42754063-53-54932
Synonyms:
1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone
1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one
1-[2-(2-Hydroxy-3-(propylamino)propoxy)phenyl]-3-phenyl-1-propanone hydrochloride
1-[2-(2-Hydroxy-3-[propylamino]- propoxy)phenyl]-3-phenyl-1-propanone
1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one
107300-59-4
2-(2'-Hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone
34183-22-7 (hydrochloride)
54063-53-5
AB00053687
AC1L1J9C
AKOS000276940
BCBcMAP01_000079
BPBio1_000437
BRD-A26334849-001-02-1
BRD-A26334849-003-05-0
BSPBio_000397
BSPBio_001465
BSPBio_003470
C07381
CHEBI:127112
CHEMBL631
CID4932
CPD001453705
D08435
DB01182
DivK1c_000906
EINECS 258-955-6
HMS1791J07
HMS1989J07
HMS2089E09
IDI1_000906
KBio1_000906
KBio2_002092
KBio2_004660
KBio2_007228
KBio3_002974
KBioGR_000817
KBioSS_002092
LS-123071
 
Lopac0_000919
MolPort-000-881-283
MolPort-002-545-323
NCGC00015819-10
NCGC00089784-02
NCGC00089784-03
NCGC00089784-04
NCGC00089784-05
NINDS_000906
P4670_SIGMA
Prestwick0_000499
Prestwick1_000499
Prestwick2_000499
Prestwick3_000499
Propafenon Hexal
Propafenon hexal (TN)
Propafenona
Propafenona [INN-Spanish]
Propafenone
Propafenone (INN)
Propafenone HCl
Propafenone Hydrochloride
Propafenone [INN:BAN]
Propafenone hydrochloride
Propafenone-HCl
Propafenonum
Propafenonum [INN-Latin]
Rythmol
Rythmol SR
S2500_Selleck
SAM002564228
SBB067234
SPBio_001605
SPBio_002318
Spectrum2_001603
Spectrum3_001905
Spectrum4_000209
Spectrum5_001271
Spectrum_001612
UNII-68IQX3T69U
propafenone
4
SotalolapprovedPhase 4373930-20-95253
Synonyms:
.beta.-Cardone
27948-47-6
3930-20-9
4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide
4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid
959-24-0 (mono-hydrochloride)
AB00514715
AC-19021
AC1L1JXU
BPBio1_001069
BRD-A33168282-003-03-2
BSPBio_000971
Betapace
C07309
C12H20N2O3S
CCRIS 4204
CHEMBL471
CID5253
D08525
DB00489
Darob mite
Darob mite (TN)
HMS2089K09
L013427
LS-90249
Lopac0_001055
MJ-1999
 
Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)- (9CI)
MolPort-002-042-381
N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide
N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide
N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide
NCGC00015919-05
NCGC00024899-02
NCGC00024899-03
Prestwick0_000966
Prestwick1_000966
Prestwick2_000966
Prestwick3_000966
SBB066409
SPBio_002892
Sorine
Sotalol
Sotalol (INN)
Sotalol HCL
Sotalol Hydrochloride
Sotalol Monohydrochloride
Sotalol [INN:BAN]
Sotalolo
Sotalolum
Sotalolum [INN-Latin]
UNII-A6D97U294I
beta-Cardone
d,l-Sotalol
sotalol
5
Amiodaroneapproved, investigationalPhase 41141951-25-32157
Synonyms:
(2-Butyl-3-benzofuranyl)(4-(2-(diethylamino)ethoxy)-3,5-diidophenyl)methanone
(2-butyl-1-benzofuran-3-yl)(4-{[2-(diethylamino)ethyl]oxy}-3,5-diiodophenyl)methanone
(2-butyl-1-benzofuran-3-yl)-[4-(2-diethylaminoethyloxy)-3,5-diiodophenyl]methanone
(2-butyl-1-benzofuran-3-yl){4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl}methanone
(2-butylbenzofuran-3-yl)-[4-(2-diethylaminoethoxy)-3,5-diiodo-phenyl]-methanone
(2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine
1951-25-3
2-Butyl-3-(3,5-diiodo-4-(2-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(3,5-diiodo-4-(beta-diethylaminoethoxy)benzoyl)benzofuran
2-Butyl-3-(4'-beta-N-diethylaminoethoxy-3',5'-diiodobenzoyl)benzofuran
2-Butyl-3-[3,5-diiodo-4-(2-di
2-Butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-((2-diethylamino)ethoxy)-m,m-diiodophenyl ketone
2-Butyl-3-benzofuranyl p-[(2-diethylamino)ethoxy]-m,m-diiodophenyl ketone
2-N-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
2-n-Butyl-3',5'-diiodo-4'-N-diethylaminoethoxy-3-benzoylbenzofuran
5-18-02-00353 (Beilstein Handbook Reference)
AB00053422
AC1L1D1R
AC1Q2VCU
ASTA Medica Brand of Amiodarone Hydrochloride
Alphapharm Brand of Amiodarone Hydrochloride
Amidorone
Aminodarone
Amio-Aqueous IV
Amiobeta
Amiodarex
Amiodarona
Amiodarona [INN-Spanish]
Amiodarone
Amiodarone (USAN/INN)
Amiodarone Base
Amiodarone HCL
Amiodarone Hydrochloride
Amiodarone [USAN:BAN:INN]
Amiodarons
Amiodaronum
Amiodaronum [INN-Latin]
Amiohexal
Amjodaronum
Ancar
Aratac
Armstrong Brand of Amiodarone Hydrochloride
Arycor
BIDD:GT0425
BIDD:PXR0146
BPBio1_000372
BRN 1271711
BSPBio_000338
BSPBio_001574
BSPBio_002580
Berenguer Infale Brand of Amiodarone Hydrochloride
Betapharm Brand of Amiodarone Hydrochloride
Bio1_000026
Bio1_000515
Bio1_001004
Bio2_000294
Bio2_000774
Braxan
C06823
C25H29I2NO3
CAS-19774-82-4
CBiol_001740
CHEBI:2663
CHEMBL633
CID2157
Corbionax
Cordarex
Cordarone
Cordarone Intravenous
D000638
D02910
DB01118
DivK1c_000079
EINECS 217-772-1
G Gam Brand of Amiodarone Hydrochloride
 
HMS1791O16
HMS1989O16
HMS2089C07
Hexal Brand of Amiodarone Hydrochloride
IDI1_000079
IDI1_034044
KBio1_000079
KBio2_000294
KBio2_000741
KBio2_002862
KBio2_003309
KBio2_005430
KBio2_005877
KBio3_000587
KBio3_000588
KBio3_001800
KBioGR_000294
KBioGR_001859
KBioSS_000294
KBioSS_000741
Ketone, 2-butyl-3-benzofuranyl 4-(2-(diethylamino)ethoxy)-3,5-diiodophenyl
Ketone, 2-butyl-3-benzofuranyl 4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl (7CI,8CI)
Kordaron
L 3428
L-3428
L001174
L3428
LS-87088
Labaz
Leurquin Brand of Amiodarone Hydrochloride
Lopac-A-8423
Lopac0_000122
MolPort-003-703-670
NCGC00015096-01
NCGC00015096-02
NCGC00015096-03
NCGC00015096-10
NCGC00024242-03
NCGC00024242-04
NCGC00024242-05
NCGC00024242-06
NCI60_041885
NINDS_000079
Nexterone
Ortacrone
Pacerone
Pharma Investi Brand of Amiodarone Hydrochloride
Prestwick0_000409
Prestwick1_000409
Prestwick2_000409
Prestwick3_000409
QTL1_000008
Rytmarone
SKF 33134-A
SKF 33134A
SPBio_001825
SPBio_002277
STK529812
STOCK1S-12240
Sanofi Winthrop Brand of Amiodarone Hydrochloride
Sedacoron
Sedacorone
Spectrum2_001813
Spectrum3_001050
Spectrum4_001190
Spectrum5_001533
Spectrum_000261
Tachydaron
UNII-N3RQ532IUT
UNM000001215003
Wyeth Brand of Amiodarone Hydrochloride
amiodarone
ethylaminoethoxy)benzoyl]benzofuran
nchembio.79-comp9
nchembio732-comp1
on
pms-Amiodarone
6
DobutamineapprovedPhase 410834368-04-236811
Synonyms:
(+-)-4-(2-((3-(P-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
(+-)-4-(2-((3-(p-Hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
3,4-Dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
34368-04-2
34368-04-2 (Parent)
4-(2-{[3-(4-hydroxyphenyl)-1-methylpropyl]amino}ethyl)benzene-1,2-diol
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
4-[2-[4-(4-hydroxyphenyl)butan-2-ylamino]ethyl]benzene-1,2-diol
4-{2-[3-(4-hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
52663-81-7 (hydrochloride)
74753-15-4
74753-15-4 (hydrobromide)
AC1L1WFF
AC1Q7AD1
BPBio1_000489
BRD-A78322124-003-03-3
BSPBio_000443
C06967
CHEBI:4670
CHEMBL926
CID36811
D03879
DB00841
DL-Dobutamine
DL-dobutamine
Dobutamin
Dobutamina
Dobutamina [INN-Spanish]
Dobutamine
Dobutamine (USP/INN)
Dobutamine Hcl
Dobutamine Hcl in Dextrose 5%
Dobutamine Hydrochloride
 
Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer
Dobutamine [USAN:BAN:INN]
Dobutamine [USAN]
Dobutamine [Usan:Ban:Inn]
Dobutamine [Usan]
Dobutamine hydrobromide
Dobutamine hydrochloride
Dobutaminum
Dobutaminum [INN-Latin]
Dobutrex
EINECS 277-982-4
HMS2089K05
Inotrex
L001157
LS-174467
LY 81929
Lilly 81929
Lopac0_000365
NCGC00015321-05
NCGC00024629-02
NCGC00024629-03
Prestwick0_000352
Prestwick1_000352
Prestwick2_000352
Prestwick3_000352
Racemic-Dobutamine
Racemic-dobutamine
SPBio_002364
UNII-0WR771DJXV
UNII-3S12J47372
dobutamine
dobutamine(usp)
rac-Dobutamine
rac-dobutamine
racemic-Dobutamine
7AnalgesicsPhase 4, Phase 29358
8Neurotransmitter AgentsPhase 414795
9Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 1, Phase 22371
10Purinergic P1 Receptor AgonistsPhase 4131
11Peripheral Nervous System AgentsPhase 4, Phase 218510
12Vasodilator AgentsPhase 42926
13Phosphodiesterase InhibitorsPhase 41062
14Contraceptives, OralPhase 43734
15Phosphodiesterase 5 InhibitorsPhase 4513
16Protective AgentsPhase 45651
17Adrenergic AgentsPhase 44204
18Adrenergic AgonistsPhase 42331
19Adrenergic beta-AgonistsPhase 41266
20SimendanPhase 451
21
ApixabanapprovedPhase 3111503612-47-310182969
Synonyms:
1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahyd
2p16
503612-47-3
AKOS005146204
Apixaban
Apixaban (JAN/USAN/INN)
Apixabanum
BMS 562247-01
BMS-562247
BMS-562247-01
 
BMS-562247-01, Apixaban
CHEBI:49620
CHEMBL231779
CID10182969
D03213
DB07828
Eliquis
GG2
S1593_Selleck
UNII-3Z9Y7UWC1J
ro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide
22Protease InhibitorsPhase 34558
23HIV Protease InhibitorsPhase 34558
24Serine Proteinase InhibitorsPhase 3705
25AnticoagulantsPhase 31760
26Factor Xa InhibitorsPhase 3315
27AntithrombinsPhase 3574
28Antithrombin IIIPhase 3563
29serineNutraceuticalPhase 3770
30
VinblastineapprovedPhase 2230865-21-413342, 241903
Synonyms:
(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE
(2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine
(2xi,3beta,4'beta,19xi)-vincaleukoblastine
(3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate
143-67-9
1z2b
29060-LE
865-21-4
AC-20335
AC1L21JC
AC1L68D2
AC1MXZJ2
BIDD:PXR0201
BRD-K01188359-065-02-5
BSPBio_001228
BSPBio_003594
Bio-0111
C07201
C46H58N4O9
CCRIS 9002
CHEBI:171516
CHEBI:27375
CHEMBL159
CHEMBL607706
CID13342
CID241903
CID3823887
CID6710780
D08675
DB00570
EINECS 212-734-0
HMS2090K05
HSDB 3263
KBio3_003033
LS-1859
LS-187263
 
MolPort-002-518-262
MolPort-005-910-359
NCGC00022585-04
NCGC00181127-01
NCI-C04842
NCI60_004200
NChemBio.2007.10-comp22
NDC 0002-1452-01
NSC 47842
Neuro_000020
Nincaluicolflastine
Rozevin
SPBio_000680
STOCK1N-38480
Spectrum2_000890
Spectrum3_001994
UNII-5V9KLZ54CY
VLB
VR-8
Velban
Velbe
Vinblastin
Vinblastina
Vinblastina (TN)
Vinblastina [DCIT]
Vinblastina [Dcit]
Vinblastine
Vinblastine (INN)
Vinblastine Sulfate
Vinblastine [INN:BAN]
Vinblastinum
Vinblastinum [INN-Latin]
Vincaleucoblastin
Vincaleucoblastine
Vincaleukoblastine
Vincoblastine
nchembio873-comp22
vinblastine
31
MethotrexateapprovedPhase 214441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
32
LosartanapprovedPhase 1, Phase 2276114798-26-43961
Synonyms:
(2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol
(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol
114798-26-4
124750-99-8 (mono-potassium salt)
1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol
2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol
2-N-Butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol
2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole
2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole
AC1L1H3Q
BIDD:GT0286
BRD-K76205745-001-02-5
BSPBio_002695
C07072
C22H23ClN6O
CHEBI:6541
CHEMBL191
CID3961
CL23623
Cozaar
D08146
DB00678
DUP 89
DuP 89
DuP-753
HMS1922J13
HMS2093E22
Hyzaar
I14-9710
Jsp001094
KBio2_002193
 
KBio2_004761
KBio2_007329
KBio3_001915
KBioGR_001611
KBioSS_002193
L000351
LOSARTAN POTASSIUM
LS-78746
Lacidipine
Lortaan
Losartan
Losartan (INN)
Losartan Potassium
Losartan [INN:BAN]
Losartan monopotassium salt
Losartic
Losartic (TN)
MK-954
MK954
MolPort-003-666-553
NCGC00095125-01
NCGC00095125-02
NCGC00095125-03
Oprea1_644635
SPBio_001893
SPECTRUM1504268
Spectrum2_001677
Spectrum3_000998
Spectrum4_001126
Spectrum5_001466
Spectrum_001713
UNII-JMS50MPO89
[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
losartan
losartan potassium
33
Bevacizumabapproved, investigationalPhase 21875216974-75-3
Synonyms:
216974-75-3
Avastin
Avastin (TN)
Bevacizumab
Bevacizumab (genetical recombination)
 
Bevacizumab (genetical recombination) (JAN)
D06409
R-435
anti-VEGF monoclonal antibody
antiVEGF
bevacizumab
34
Folic Acidapproved, nutraceuticalPhase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
35
PirfenidoneinvestigationalPhase 24253179-13-840632
Synonyms:
5-21-07-00197 (Beilstein Handbook Reference)
5-Methyl-1-phenyl-1H-pyridin-2-one
5-Methyl-1-phenyl-2(1H)-pyridone
5-Methyl-1-phenyl-2-(1H)-pyridone
5-methyl-1-phenylpyridin-2(1H)-one
5-methyl-1-phenylpyridin-2-one
53179-13-8
AC-6797
AC1L2454
AMR 69
AMR-69
BRD-K96862998-001-03-1
BRN 1526549
Bio1_000397
Bio1_000886
Bio1_001375
C093844
C12H11NO
CID40632
D01583
Deskar
EN000704
EU-0100907
Esbriet
F-647
FT-0082541
 
I01-1466
KS-5041
LS-133834
Lopac-P-2116
Lopac0_000907
MLS000860042
NCGC00015806-01
NCGC00015806-03
NCGC00015806-05
NCGC00024992-01
NCGC00024992-02
NCGC00024992-03
P 2116
P2116_SIGMA
PIRFENIDONE
Pirespa
Pirfenidona
Pirfenidona [INN-Spanish]
Pirfenidone (Deskar)
Pirfenidone (JAN/USAN/INN)
Pirfenidone [USAN:INN]
Pirfenidonum
Pirfenidonum [INN-Latin]
S-7701
SMR000326900
Tocris-1093
ZINC00001958
36Tubulin ModulatorsPhase 24279
37Nucleic Acid Synthesis InhibitorsPhase 23836
38Anti-Inflammatory Agents, Non-SteroidalPhase 23549
39Anti-Inflammatory AgentsPhase 28478
40Analgesics, Non-NarcoticPhase 25184
41Vitamin B ComplexPhase 22847
42AntimetabolitesPhase 29454
43Antirheumatic AgentsPhase 28496
44Antineoplastic Agents, PhytogenicPhase 24294
45Immunosuppressive AgentsPhase 210422
46Antimetabolites, AntineoplasticPhase 25770
47Dermatologic AgentsPhase 24555
48Antimitotic AgentsPhase 24296
49Folic Acid AntagonistsPhase 21643
50Immunologic FactorsPhase 218483

Interventional clinical trials:

(show top 50)    (show all 52)
idNameStatusNCT IDPhase
1Randomized Trial of Two Ablation Catheters in Paroxysmal Atrial FibrillationCompletedNCT00678340Phase 4
2PV-Isolation With the Cryoballoon Versus RF:a Randomized Controlled Prospective Non-inferiority Trial (FreezeAF)CompletedNCT00774566Phase 4
3ADenosine Following Pulmonary Vein Isolation to Target Dormant Conduction Elimination: the ADVICE TrialCompletedNCT01058980Phase 4
4Additional Linear Ablation Beyond Pulmonary Vein Isolation for Paroxysmal Atrial FibrillationRecruitingNCT02637453Phase 4
5Cardioversion vs. Catheter Ablation for Persistent Atrial FibrillationRecruitingNCT00196209Phase 4
6A Prospective Randomized Study Comparing Radiofrequency Energy With CryoenergyRecruitingNCT00773539Phase 4
7Aortic Stenosis and PhosphodiEsterase Type 5 iNhibition (ASPEN): A Pilot StudyRecruitingNCT01275339Phase 4
8Kansai Plus Atrial Fibrillation TrialActive, not recruitingNCT01477983Phase 4
9The Effects of Dobutamine on Postoperative Cardiac Function in Aortic Valve ReplacementSuspendedNCT01375335Phase 4
10Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial FibrillationTerminatedNCT01061931Phase 4
11Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®)TerminatedNCT01116557Phase 4
12Aortic Stenosis and PhosphodiEsterase iNhibition With Aortic Valve Replacement (ASPEN-AVR): A Pilot StudyTerminatedNCT01272388Phase 4
13Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular HypertrophyTerminatedNCT01188369Phase 4
14Prevention of Autogenous Vein Graft Failure in Coronary Artery Bypass ProceduresCompletedNCT00042081Phase 3
15Evaluation of the Phased Radio Frequency Ablation SystemRecruitingNCT01693120Phase 3
16SOLAR & ATRILAZE Atrial Fibrillation TrialNot yet recruitingNCT00734058Phase 3
17Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic StenosisNot yet recruitingNCT02664649Phase 3
18Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial FibrillationTerminatedNCT00741611Phase 3
19Vinblastine and Methotrexate in Children With Pulmonary Vein StenosisCompletedNCT00215046Phase 2
20Treatment of Atrial Fibrillation by Minimal Invasive SurgeryCompletedNCT00448656Phase 2
21REVOLUTION (WFCC-133) - Treatment of Paroxysmal Atrial FibrillationCompletedNCT01353586Phase 2
22Pirfenidone to Treat Hypertrophic CardiomyopathyCompletedNCT00011076Phase 2
23Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein StenosisRecruitingNCT02769130Phase 1, Phase 2
24Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein StenosisActive, not recruitingNCT00891527Phase 2
25Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve SurgeryActive, not recruitingNCT00903370Phase 2
26RF Ablation of Atrial FibrillationCompletedNCT00265629Phase 1
27MRI to Detect Embolism Following Angiography and Angioplasty-Stenting of the Renal ArteryCompletedNCT00027469Phase 1
28Transcaval Access for Transcatheter Aortic Valve Replacement in People With No Good Options for Aortic AccessRecruitingNCT02280824Phase 1
29A Study of Strategies for Electrical Isolation of Pulmonic Veins for Curative Treatment of Atrial FibrillationCompletedNCT00434694
30STAR-AF:Substrate Versus Trigger Ablation for Reduction of Atrial Fibrillation TrialCompletedNCT00367757
31Radiofrequency Ablation of Drivers of Atrial FibrillationCompletedNCT00674401
32Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II StudyCompletedNCT01203748
33The Effects of High Spinal Anesthesia on Heart Function, Stress Response and Pain Control in Aortic Valve SurgeryCompletedNCT00348920
34Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG)CompletedNCT01310725
35The Role of Heart Stiff and Weak Atrium on Exercise Capacity in Patients With Hypertrophic CardiomyopathyCompletedNCT00074880
36Safety Monitoring of Patients Having Pulmonary Vein AblationRecruitingNCT00590668
37Effectiveness Study of Circumferential vs. Segmental Ablation in Paroxysmal Atrial FibrillationRecruitingNCT02106663
38Non-invasive Characterization of the Mechanisms of Atrial Fibrillation MaintenanceRecruitingNCT02497248
39Ablation and Left Atrium Reduction During Mitral Valve Surgery for Atrial FibrillationRecruitingNCT02047279
40Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation AblationRecruitingNCT01851525
41National Congenital Heart Disease AuditRecruitingNCT02303535
42Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term OutcomesRecruitingNCT00163956
43T Cell Effector and Regulatory Mechanisms in AsthmaRecruitingNCT01612936
44Diagnostic Imaging Strategies for Patients With Stable Chest Pain and Intermediate Risk of Coronary Artery DiseaseRecruitingNCT02400229
45Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency DepartmentRecruitingNCT02781207
46FREEZE Cohort StudyActive, not recruitingNCT01360008
47Efficacy of Delayed Enhancement MRI-Guided Ablation vs Conventional Catheter Ablation of Atrial FibrillationNot yet recruitingNCT02529319
48Antiplatelet Therapy Continuation in Spine Surgery - Its Effect on Postoperative Morbidity and MortalityNot yet recruitingNCT01006083
49Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein StenosisTerminatedNCT00215059
50Surgical Pulmonary Vein Isolation Efficiency StudyTerminatedNCT01791218

Search NIH Clinical Center for Pulmonary Vein Stenosis

Genetic Tests for Pulmonary Vein Stenosis

About this section

Anatomical Context for Pulmonary Vein Stenosis

About this section

MalaCards organs/tissues related to Pulmonary Vein Stenosis:

33
Lung, Heart, T cells, Endothelial, Prostate, Breast, Bone

Animal Models for Pulmonary Vein Stenosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Pulmonary Vein Stenosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053847.4ACTC1, DES, F2RL1, PDGFRA, PECAM1, TYMP

Publications for Pulmonary Vein Stenosis

About this section

Articles related to Pulmonary Vein Stenosis:

(show top 50)    (show all 227)
idTitleAuthorsYear
1
Down Syndrome with Complete Atrioventricular Septal Defect, Hypertrophic Cardiomyopathy, and Pulmonary Vein Stenosis. (26504441)
2015
2
Surgical repair for primary pulmonary vein stenosis: Single-institution, midterm follow-up. (25935589)
2015
3
Successful stenting of left pulmonary veins stenosis resulting from fibrosing mediastinitis. (25586119)
2015
4
Pulmonary Hypertension in the Preterm Infant with Chronic Lung Disease can be Caused by Pulmonary Vein Stenosis: A Must-Know Entity. (26573816)
2015
5
Pulmonary vein stenosis: Challenges ahead. (26277464)
2015
6
Pulmonary vein stenosis after pulmonary vein isolation using duty-cycled unipolar/bipolar radiofrequency ablation guided by intracardiac echocardiography. (26081432)
2015
7
Multiple and aggressive pulmonary vein transcatheter interventions as bridge to transplantation in primary diffuse pulmonary vein stenosis. (26015092)
2015
8
A Novel Hybrid Approach for Balloon Dilation of Pulmonary Vein Stenosis Following Total Anomalous Pulmonary Venous Connection Repair with Atrial Septal Patching. (25973524)
2015
9
Pulmonary Vein Stenosis Mimicking Nonspecific Interstitial Pneumonia. (26779359)
2015
10
Pulmonary Vein Stenosis After Cryoablation Using 28-mm Second-Generation Balloon. (25511425)
2014
11
Congenital pulmonary vein stenosis in an adult patient. (24184251)
2014
12
Hemoptysis from bronchial varices associated with pulmonary vein stenosis: role of surgical repair. (22997173)
2013
13
Severe pulmonary vein stenosis due to invasion of metastatic lung cancer. (23443870)
2013
14
Pulmonary Vein Stenosis with Down Syndrome: A Rare and Frequently Fatal Cause of Pulmonary Hypertension in Infants and Children. (23650870)
2013
15
Proximal pulmonary vein stenosis detection in pediatric patients: value of multiplanar and 3-D VR imaging evaluation. (23475282)
2013
16
Bifurcation angioplasty using drug eluting stents of post-AF ablation severe pulmonary vein stenosis. (22394418)
2012
17
Percutaneous stenting to treat pulmonary vein stenosis after single-lung transplantation. (22949779)
2012
18
Sutureless technique for recurrent pulmonary vein stenosis after pericardial patchplasty in an adult. (22901499)
2012
19
Successful correction of unroofed coronary sinus with pulmonary vein stenosis. (22753625)
2012
20
Isolated congenital left-sided pulmonary vein stenosis in an adult patient misdiagnosed as primary pulmonary hypertension. (21349107)
2011
21
Surgical management of post-repair pulmonary vein stenosis. (21444056)
2011
22
Evaluation of pulmonary vein stenosis after pulmonary vein isolation using a novel circular mapping and ablation catheter (PVAC). (21841188)
2011
23
Cardiopulmonary hemodynamic clues for pulmonary vein stenosis diagnosis. (22530105)
2011
24
Unmasking of patent ductus arteriosus on cardiopulmonary bypass: role of intraoperative trans-esophageal echocardiography in a patient with severe pulmonary hypertension due to pulmonary vein stenosis and cor triatriatum. (21636939)
2011
25
Acquired pulmonary vein stenosis: one problem, two mechanisms. (20138470)
2010
26
Importance of totally anomalous pulmonary venous connection and postoperative pulmonary vein stenosis in outcomes of heterotaxy syndrome. (18004616)
2008
27
Pulmonary vein stenosis: intervene early and carry a big stent. (18373597)
2008
28
Primary pulmonary vein stenosis. (17293205)
2007
29
Detection of pulmonary vein stenosis by transesophageal echocardiography: comparison with multidetector computed tomography. (17452156)
2007
30
Transesophageal echocardiography: a follow-up tool after catheter ablation of atrial fibrillation and interventional therapy of pulmonary vein stenosis and occlusion. (17458690)
2007
31
Management of congenital and acquired pulmonary vein stenosis. (16488708)
2006
32
Acquired isolated left pulmonary vein stenosis: a complication of bronchogenic cyst removal diagnosed by transesophageal echocardiography. (16412190)
2006
33
Temporary pulmonary vein stenosis during intraoperative transesophageal echocardiography in total cavopulmonary connection. (16235015)
2006
34
Usefulness of helical computed tomography in diagnosing pulmonary vein stenosis in infants. (16049562)
2005
35
Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging. (15302728)
2004
36
A case of congenital pulmonary vein stenosis in an adult. (14872119)
2004
37
Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis. (12932615)
2003
38
Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. (12952852)
2003
39
Pulmonary vein stenosis by ostial irrigated-tip ablation: incidence, time course, and prediction. (12693497)
2003
40
Successful stent treatment of pulmonary vein stenosis following atrial fibrillation radiofrequency ablation. (12082196)
2002
41
Congenital pulmonary vein stenosis associated with cor triatriatum. (11235744)
2001
42
Left upper pulmonary vein stenosis 2 months after radiofrequency catheter ablation of atrial fibrillation. (10747360)
2000
43
Pulmonary vein stenosis complicating catheter ablation of focal atrial fibrillation. (10868741)
2000
44
Pulmonary vein stenosis with normal connection: associated cardiac abnormalities and variable outcome. (10421134)
1999
45
Pulmonary vein stenosis after catheter ablation of atrial fibrillation. (9788832)
1998
46
Lung transplantation for congenital pulmonary vein stenosis. (7574992)
1995
47
Pulsed wave and color Doppler findings in congenital pulmonary vein stenosis. (1614915)
1992
48
Radionuclide evaluation of unilateral pulmonary vein stenosis. Correlation with chest roentgenogram and clinical profiles. (3295141)
1986
49
Congenital pulmonary vein stenosis: a radiographic study. (3763853)
1986
50
Congenital pulmonary vein stenosis. (6465018)
1984

Variations for Pulmonary Vein Stenosis

About this section

Expression for genes affiliated with Pulmonary Vein Stenosis

About this section
Search GEO for disease gene expression data for Pulmonary Vein Stenosis.

Pathways for genes affiliated with Pulmonary Vein Stenosis

About this section

Pathways related to Pulmonary Vein Stenosis according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.8ACTC1, DES
29.5ACTC1, PDGFRA

GO Terms for genes affiliated with Pulmonary Vein Stenosis

About this section

Biological processes related to Pulmonary Vein Stenosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of cytosolic calcium ion concentrationGO:00072049.4F2RL1, PDGFRA
2positive regulation of phosphatidylinositol 3-kinase signalingGO:00140689.1F2RL1, PDGFRA

Sources for Pulmonary Vein Stenosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet